The effect of intra-vitreal injection of bevacizumab for vascular endothelial factor-related intraocular diseases.
Not Applicable
- Conditions
- choroidal neovascularization, retinal vein occlusion, diabetic retinopathy, diabetic maculopathy, neovascular glaucoma
- Registration Number
- JPRN-UMIN000013974
- Lead Sponsor
- Department of Ophthalmology, Matsumoto Dental University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 3
Inclusion Criteria
Not provided
Exclusion Criteria
Patietns with uncontroled hypertension or with systemic risk factors of cerebral infarction or cardial infarction.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Varidation on the visula acuity at 1, 3, 6, 12 months after intravitreal injection
- Secondary Outcome Measures
Name Time Method Examination of macular forrmation and thickness by optical coherence tomography